NZOZ Eskulap Pabianice

Pabianice 95-200

2 studies enrolling now · 2 studies all time

What they study most

Moderately to Severely Active Crohns Disease, Obesity or Overweight, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes — Recruiting now